Hypothesis

Repeated low‑grade pain triggers a transient mitochondrial ROS burst in sensory neurons that releases lactate into the bloodstream; this lactate is taken up by circulating monocytes where it inhibits histone deacetylases, increasing histone lactylation at promoters of trained‑immunity genes. The resulting epigenetic reprogramming enhances monocyte responsiveness to secondary challenges, contributing to systemic resilience. Chronic analgesic use suppresses the ROS‑lactate signal, impairing this hormetic priming and accelerating immune aging.

Mechanistic Basis

• Pain‑induced activation of TRPV1 and substance P elevates intracellular Ca²⁺, stimulating mitochondrial electron‑chain leak and ROS production [1].
• ROS activate HIF‑1α, shifting neurons to aerobic glycolysis and exporting lactate via MCT4.
• Extracellular lactate enters monocytes through MCT1, where it accumulates and inhibits class I HDACs, promoting histone lactylation (Kla) at NF‑κB‑target loci such as IL6, TNF, and NLRP3 [2].
• Histone Kla loosens chromatin, facilitating faster transcriptional rewiring upon secondary stimuli—a mechanism analogous to beta‑glucan–induced trained immunity but driven by neuronal‑derived lactate rather than microbial ligands.
• NSAIDs (e.g., diclofenac) inhibit COX‑derived prostaglandins that normally amplify NRF2‑mediated antioxidant responses, thereby dampening the ROS lactate axis [3]. Opioids suppress neuronal activity and mitochondrial metabolism, further reducing lactate efflux [4].

Testable Predictions

1. Healthy volunteers exposed to a standardized, brief pain stimulus (e.g., cuff‑induced ischemia) will show a transient rise in plasma lactate and increased monocyte histone H3K18la levels within 2 h, returning to baseline by 24 h.
2. Pretreatment with ibuprofen or morphine will blunt the pain‑evoked lactate surge and prevent the rise in monocyte histone lactylation.
3. Monocytes isolated after pain exposure will exhibit enhanced cytokine production and improved phagocytosis when re‑challenged with LPS or β‑glucan 24 h later; this boost will be absent in analgesic‑treated subjects.
4. In aged mice, chronic low‑dose NSAID administration will reduce neuronal lactate release, lower monocyte histone Kla, and accelerate age‑related decline in vaccine‑like responses to a secondary immune challenge.

Experimental Approach

• Human crossover study: n=30 young adults receive either placebo, ibuprofen (400 mg), or oral morphine (10 mg) before a 5‑minute tourniquet pain test. Blood drawn at 0, 2, 6, 24 h for lactate ELISA, monocyte isolation, Western blot for H3K18la, and ex vivo LPS stimulation (IL‑6/TNF ELISA).
• Mouse model: aged C57BL/6 mice (20 mo) receive chronic ibuprofen in chow (30 ppm) for 8 weeks vs control. Measure DRG neuronal lactate (microdialysis), blood monocyte histone Kla (ChIP‑qPCR), and response to a secondary low‑dose LPS challenge (survival, cytokine storm).
• Use HDAC‑specific inhibitors and MCT1 blockers to dissect causality.

If confirmed, this hypothesis reframes acute pain as a lactate‑mediated hormonal signal that tunes innate immune epigenetics, suggesting that indiscriminate analgesic silencing may trade short‑term comfort for long‑term immune fragility.